The Crohn’s and Colitis Foundation’s 34th annual Torch Gala is set to take place on Saturday, Feb. 8 in Atlanta, with three ...

"Our study suggests that vedolizumab is a viable option for induction and long-term maintenance therapy in children with IBD, ...

The multicentre, prospective, cohort study by Ohad Atia and colleagues1 on the long-term efficacy and safety of maintenance vedolizumab in paediatric patients with inflammatory bowel disease (IBD) ...

For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurative (HS) and inflammatory disease space: patient quality of life, medication and ...

Four years ago, over dinner and drinks, five Buckhead moms hatched a bold plan to turn their love of softball into a lifeline for those battling Crohn’s disease.

For many people with Crohn’s disease, reaching remission—when inflammation is no longer detectable—seems like a major victory ...

A Medical University of South Carolina Hollings Cancer Center researcher is exploring new ways to improve treatment options for kidney cancer patients.

Steqeyma is approved for adult and pediatric patients with plaque psoriasis and active psoriatic arthritis as well as adults ...

Even with aggressive treatment, a bowel perforation with peritonitis poses ... Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based ...

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new study shows.

Unfortunately, IBD, as well as treatment, have both steadily increased in the last few years. Specifically, Crohn’s disease affects up to 300 people for every 100,000 in North America. Individuals of ...